Smokers versus non-smokers undergoing percutaneous transluminal coronary angioplasty: The impact of clinical and procedural characteristics on in-hospital mortality

Cardiology Journal

Volumn 14, Issue 5, 2007, Pages 482-492

  Sukiennik, Adam ^a   Koziński, Marek ^a   Debska Kozińska, Katarzyna ^a   Kubica, Aldona ^a   Grabczewska, Zofia ^a   Kubica, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Comorbidities; In hospital mortality; Percutaneous transluminal coronary angioplasty; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITAL CARE; HUMAN; HYPERTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PREVALENCE; RADIATION EXPOSURE; RETROSPECTIVE STUDY; REVASCULARIZATION; SEX DIFFERENCE; SMOKING; SURVIVAL; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION; TREND STUDY; UNIVARIATE ANALYSIS; UNSTABLE ANGINA PECTORIS;

EID: 39549118129     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Weaver WD, Simes RJ, Betriu. A et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA, 1997; 278: 2093-2098.
2. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Lancet, 2000; 356: 9-16.
3. Henderson RA, Pocock SJ, Clayton TC et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol, 2003; 42: 1161-1170.
4. Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2006; 113: e85-e151.
5. Baba S, Iso H, Mannami T et al. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I. Eur J Cardiovasc Prev Rehabil, 2006; 13: 207-213.
6. Katz A, Grosbard A. Does it all go up in smoke? Cigarette smoking and tachyarrhythmias. J Cardiovasc Electrophysiol, 2006; 17: 937-939.
7. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lemon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J, 2005; 26: 1765-1773.
8. Bellet S, Horstmann E, Roman LR, DeGuzman NT, Kostis JB. Effect of caffeine on the ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J, 1972; 84: 215-227.
9. Tachmes L, Fernandez RJ, Sackner MA. Hemodynamic effects of smoking cigarettes of high and low nicotine content. Chest, 1978; 74: 243-246.
10. Maouad J, Fernandez F, Barrillon A, Gerbaux A, Gay J. Diffuse or segmental narrowing (spasm) of the coronary arteries during smoking demonstrated on angiography. Am J Cardiol, 1984; 53: 354-355.
11. Wald N, Howard S, Smith PG, Kjeldsen K. Association between atherosclerotic diseases and carboxy-haemoglobin levels in tobacco smokers. BMJ, 1973; 1: 761-765.
12. Grines CL, Topol EJ, O'Neill WW et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation, 1995; 91: 298-303.
13. Barbash GI, Reiner J, White HD et al. Evaluation of paradoxical beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol, 1995; 26: 1222-1229.
14. Angeja BG, Kermgard S, Chen MS et al. The smoker's paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis, 2002; 13: 133-139.
15. Ruiz-Bailen M, de Hoyos EA, Reina-Toral A, Torres-Ruiz JM, Alvarez-Bueno M, Gomez Jimenez FJ. Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: results of the ARIAM Register. Chest, 2004; 125: 831-840.
16. Gibbons RJ, Abrams J, Chatterjee K et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation, 2003; 107: 149-158.
17. Bertrand ME, Simoons ML, Fox KA et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J, 2002; 23: 1809-1840.
18. van de Werf F, Ardissino D, Betriu A et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J, 2003; 24: 28-66.
19. Chen Z, Boreham J. Smoking and cardiovascular disease. Semin Vasc Med, 2002; 2: 243-252.
20. Teo KK, Ounpuu S, Hawken S et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet, 2006; 368: 647-658.
21. Blinc A. The misleading "smoker's paradox". E-journal of Cardiology Practice. http://www.escardio.org/knowledge/ cardiology_practice/ejournal_vo14/vo14n15.htm. Assessed on 07.09.2007.
22. Deckers JW. Smoking and survival in acute coronary syndrome: the fog is clearing. Eur Heart J, 2001; 22: 724-726.
23. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med, 1997; 336: 1276-1282.
24. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation, 1998; 97: 2110-2116.
25. Purcell IF, Newall N, Farrer M. Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis. QJM, 1999; 92: 327-333.
26. Zahger D, Cercek B, Cannon CP et al. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial). Am J Cardiol, 1995; 75: 232-236.
27. de Chillou C, Riff P, Sadoul N et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol, 1996; 27: 1662-1668.
28. Perera D, Postema P, Rashid R et al. Does a well developed collateral circulation predispose to restenosis after percutaneous coronary intervention? An intravascular ultrasound study. Heart, 2006; 92: 763-767.
29. Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der Graaf Y. Coronary collateral circulation: The effects of smoking and alcohol. Atherosclerosis, 2007; 191: 191-198.
30. Abaci A, Oguzhan A, Kahraman S et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation, 1999; 99: 2239-2242.
31. Nisanci Y, Sezer M, Umman B, Yilmaz E, Mercanoglu S, Ozsaruhan O. Relationship between pressure-derived collateral blood flow and diabetes mellitus in patients with stable angina pectoris: a study based on coronary pressure measurement. J Invasive Cardiol, 2002; 14: 118-122.
32. Jorgensen S, Kober L, Ottesen MM, Torp-Pedersen C, Videbaek J, Kjoller E. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients. J Cardiovasc Risk, 1999; 6: 23-27.
33. Gottlieb S, Boyko V, Zahger D et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol, 1996; 28: 1506-1513.
34. Gourlay SG, Rundle AC, Barron HV. Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). Nicotine Tob Res, 2002; 4: 101-107.
35. Himbert D, Klutman M, Steg G, White K, Gulba DC; the GRACE Investigators. Cigarette smoking and acute coronary syndromes: a multinational observational study. Int J Cardiol, 2005; 100: 109-117.
36. Bowers TR, Terrien EF, O'Neill WW, Sachs D, Grines CL. Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). Am J Cardiol, 1996; 78: 511-515.
37. Weisz G, Cox DA, Garcia E et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited. Am Heart J, 2005; 150: 358-364.
38. Hasdai D, Lerman A, Rihal CS et al. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J, 1999; 137: 612-620.
39. Kinjo K, Sato H, Sakata Y et al. Impact of smoking status on long-term mortality in patients with acute myocardial infarction. Circ J, 2005; 69: 7-12.
40. Gasior M, Gierlotka M, Wasilewski J et al. Influence of smoking on early outcome of treatment of patients with acute myocardial infarction treated with coronary angioplasty. Folia Cardiol, 2003; 10: 743-749.
41. Robertson JO, Lincoff AM, Wolski K, Topol EJ. Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary intervention. Am J Cardiol, 2006; 97: 1679-1684.
42. Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med, 1997; 336: 755-761.
43. Violaris AG, Thury A, Regar E, Melkert R, Serruys PW. Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty. Heart, 2000; 84: 299-306.
44. Galan KM, Deligonul U, Kern MJ, Chaitman BR, Vandormael MG. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol, 1988; 61: 260-263.
45. Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ, Kuntz RE. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation, 2001; 104: 773-778.
46. Sonke GS, Stewart AW, Beaglehole R, Jackson R, White HD. Comparison of case fatality in smokers and non-smokers after acute cardiac event. BMJ, 1997; 315: 992-993.